300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Retail
Oil and Gas
Payments
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Social
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Infrastructure
Beauty
Fashion
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Bruce Luehrs, Founder , Managing Partner; Partner at Rittenhouse Ventures

Bruce Luehrs

Founder , Managing Partner; Partner @ Rittenhouse Ventures

Greater Philadelphia Area, United States

Bruce Luehrs is a Series A investor at Rittenhouse Ventures in Greater Philadelphia Area focused on Software and Health Care. Bruce Luehrs - Partner @ Rittenhouse Ventures

Total investments:
19
Last investment:
Lead investor:
63%

Last updated:

Industries Bruce Luehrs invests in

SoftwareHealth CareEnterprise SoftwareAnalyticsBiotechnology

Stages Bruce Luehrs invests in

Series ASeries BSeries CFunding Round

Countries Bruce Luehrs invests in

United States

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Software 4 (21%)
  • Health Care 4 (21%)
  • Enterprise Software 3 (16%)
  • Analytics 2 (11%)
  • Biotechnology 2 (11%)
See all 31 industries →

Stage

  • Series A 5 (26%)
  • Series B 2 (11%)
  • Series C 2 (11%)
  • Funding Round 1 (5%)

Investments

CompanyDescriptionRoundLinks
AI-powered clinical imaging intelligence for drug development. We make imaging a strategic asset: faster trials, stronger evidence, more confident decisions. $11M / Series C / Mar 12, 2020
AI-powered clinical imaging intelligence for drug development. We make imaging a strategic asset: faster trials, stronger evidence, more confident decisions. $5.1M / Series B / Dec 20, 2016
DecisionSim is a simulation-based learning platform that enhances decision-making by allowing organizations to easily create assessment, education, and training programs that deliver insights and improve outcomes through “real-world” engagement. $1.9M / Series A / Sep 02, 2015
Noble Biomaterials is a global leader in antimicrobial and conductivity solutions for soft surface applications. They supply medical components to the US military, and a US EPA–registered antimicrobial manufacturer. Series C / Jul 01, 2013
vcopious is your in virtual environments for Training, Conferences, Trade Shows, Webinars, Seminars, Career Fairs, and Briefings. vcopious is a virtual environment software platform that enables companies to connect with their global communities to build brands, increase lead generation and engage target audiences. By capturing relevant usermetrics in real time, vcopious enables companies to gain actionable insights for applications ranging from product launches, customer service portals and hybrid conferences, to employee training and virtual events. vcopious software can be deployed in a licensed, hosted or SAAS environment. The vcopious software platform enables enterprises to seamlessly connect relevant internal assets, including E-commerce, CRM, social media, customer records, learning systems and contact centers, while collecting every user activity within the platform. vcopious is a leading cost-reduction and revenue enhancement strategy for multinational organizations across industry categories. Oct 10, 2011
Miria Systems, Inc., is a provider of Digital Business Automation Solutions in the cloud. Miria offers advanced technology solutions built on the IBM DBA Platform, for capture & OCR, AP Automation, Payment Automation & Optimization, and automation of other financial processes. Miria offers additional applications to completely configure thefull ActiveOps solution to each unique business. As a subsidiary of OSG Billing, and an IBM Gold Business Partner, Miria enables the digital transformation of business processes through the highest standards of advanced digital business automation technologies. Series A / Apr 29, 2011
CareKinesis, Inc. provides state-of-the-art medication management through a combination of technology, science and services that reduces costs, improves the quality of care and decreases the risks associated with ineffective medication plans. $1.5M / Series B / Apr 07, 2011
CareKinesis, Inc. provides state-of-the-art medication management through a combination of technology, science and services that reduces costs, improves the quality of care and decreases the risks associated with ineffective medication plans. $1.5M / Series A / Oct 11, 2010
Core Solutions (CORE) is a market leader in providing electronic health records (EHR) technology for the behavioral healthcare and human services industries. With its proven technology platform, Cx360, CORE offers its customers a comprehensive enterprise suite designed to fit the needs of its clients. When you choose Core Solutions as your softwareprovider, you get the training, services, and expertise that come with over 10 years of experience, along with a platform that saves agencies more than $21 Million annually by reducing their denied claims. With Cx360, 98% of all claims are accepted the FIRST TIME. Series A / Dec 19, 2008
AlignAlytics provides software, experience and services to help companies drive improved business outcomes with analytics. Series A / Jun 20, 2008
See all 19 investments →

Co-Investors

Rittenhouse Ventures

About Rittenhouse Ventures

VC Fund · Philadelphia, United States

Rittenhouse Ventures is a Philadelphia-based early-stage venture fund that invests in capital-efficient emerging technology companies across Pennsylvania and the Mid-Atlantic region. Rittenhouse invests in small (generally $1 to $3 million) financing rounds of early-stage information technology companies that utilize emerging technologies to createcompelling business opportunities. While the Fund invests across the information technology spectrum, it has a primary vertical focus on Healthcare Information Technology and Pharmaceutical IT. It also invests in Technology-Enabled Services companies focused on other verticals including Financial Services Information Technology and Outsourced Business Services.

Rittenhouse Ventures Contacts

NameEmailPhoneSocials
Britton H. Murdoch
Britton H. Murdoch Fund Principal
Bruce Luehrs
Bruce Luehrs Founder , Managing Partner; Partner
David Nevas
David Nevas Partner
Justin Hanley
Justin Hanley Associate
Saul Richter
Saul Richter Founder & Managing Partner

Sign up to unlock verified contacts

Unlock Contacts

See all 6 contacts →

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Retail
Oil and Gas
Payments
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Social
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Infrastructure
Beauty
Fashion
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Bruce Luehrs invest in?

Bruce Luehrs invests primarily in Software, Health Care and Enterprise Software startups, most often at Series A and Series B stage. Most of the 19 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Bruce Luehrs?

Public channels for Bruce Luehrs include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Bruce Luehrs last invest?

The most recent investment recorded for Bruce Luehrs closed in Mar 2020. Shizune tracks 19 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Bruce Luehrs Bruce Luehrs Find email